CorMedix (CRMD) Stock: Gaining Ahead Of Financial Results

After announcing the coming release of its financial results, CorMedix Inc. (NYSEAMERICAN: CRMD) is climbing in the market today. Investors seem to be excited for the report that will be coming a week from today. Below, we’ll talk about:

  • The news and more;
  • what we’re seeing from CRMD stock; and
  • what we’ll be watching for ahead.

Here’ What’s Going On With CRMD

As mentioned above, CorMedix is having a strong day in the market today. The gains come on the heels of incredible gains experienced yesterday.

Yesterday’s movement was the result of a calendar surfacing, showing that CRMD will be a presenter at the Roth Conference, one of the most important conferences in the space. However, today’s gains are the result of something completely different.

In a press release issued early this morning, the company announced that it will be reporting its financial results for the fourth quarter and full year relatively soon. In fact, the report is expected to be released after the closing bell on Thursday, March 14, 2019.

The company also plans on hosting a conference call at 4:30 that day to discuss its financial results. If you’re interested in joining the conference call, you can do so using the infromation below:

Thursday, March 14 at 4:30pm Eastern Time
Domestic: 877-407-9124
International: 201-689-8584
Conference ID: 13688391

Replays, Available through March 28, 2019:
Domestic: 877-481-4010
International: 919-882-2331
Replay PIN: 45037

The gains that we’ve seen yesterday and today may just be the beginning. Recent, and overwhelmingly positive discussions with the FDA surrounding Neutrolin and strong data supporting the drug suggest that we will hear about the progress that the company is making in the development of the treatment.

What We’re Seeing From The Stock 

One of the first lessons that we learn when we start to work in the market is that the news leads to moves. In the case of CorMedix, the news proved to be overwhelmingly positive.

The company is not only going to be presenting at Roth, it will also be providing its financial results, all of which will be happening over the next two weeks. With all of this news coming, investors are excited, as can be seen from the gains on the stock.

As is just about always the case, our partners at Trade Ideas were the first to alert us to the movement. Currently (10:56), CRMD is trading at $1.87 per share after a gain of $0.10 per share or 5.65% thus far today.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What We’ll Be Watching For Ahead

Moving forward, the CNA Finance team will continue to keep a close eye on CRMD. In particular, we’re interested in following the story surrounding the company’s continued work to bring Neutrolin to market. Nonetheless, we’ll keep a close eye on the news and bring it to you as it breaks!

Never Miss The News Again

Do you want real-time, actionable news delivered to your inbox? Join the CNA Finance mailing list below!

Subscribe Today!

* indicates required

Leave a Comment